Edwards Lifesciences Corporation (EW)
NYSE: EW · Real-Time Price · USD
74.81
+0.88 (1.19%)
Dec 20, 2024, 4:00 PM EST - Market closed
Edwards Lifesciences Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
Revenue | 6,315 | 6,005 | 5,382 | 5,233 | 4,386 | 4,348 | Upgrade
|
Revenue Growth (YoY) | 24.02% | 11.56% | 2.86% | 19.29% | 0.88% | 16.79% | Upgrade
|
Cost of Revenue | 1,478 | 1,380 | 1,079 | 1,249 | 1,081 | 1,114 | Upgrade
|
Gross Profit | 4,837 | 4,625 | 4,304 | 3,984 | 3,306 | 3,234 | Upgrade
|
Selling, General & Admin | 1,955 | 1,823 | 1,567 | 1,494 | 1,229 | 1,242 | Upgrade
|
Research & Development | 1,133 | 1,072 | 945.2 | 903.1 | 760.7 | 752.7 | Upgrade
|
Other Operating Expenses | -153.6 | - | - | - | - | - | Upgrade
|
Operating Expenses | 2,934 | 2,895 | 2,512 | 2,397 | 1,990 | 1,995 | Upgrade
|
Operating Income | 1,903 | 1,730 | 1,792 | 1,587 | 1,316 | 1,239 | Upgrade
|
Interest Expense | -17.6 | -17.6 | -19.2 | -18.4 | -15.8 | -20.7 | Upgrade
|
Interest & Investment Income | 84.4 | 67.2 | 35.5 | 17.4 | 23.4 | 32.2 | Upgrade
|
Earnings From Equity Investments | - | - | - | - | 0.9 | 0.9 | Upgrade
|
Currency Exchange Gain (Loss) | 10.4 | 10.5 | -1.2 | 5 | 12.3 | 5.9 | Upgrade
|
Other Non Operating Income (Expenses) | 36.9 | 11.5 | 18.8 | 10.8 | -1 | 2 | Upgrade
|
EBT Excluding Unusual Items | 2,017 | 1,801 | 1,826 | 1,601 | 1,336 | 1,259 | Upgrade
|
Merger & Restructuring Charges | -32.9 | - | -62.3 | - | - | - | Upgrade
|
Gain (Loss) on Sale of Investments | -2.5 | -8.8 | -19.9 | -2.8 | -0.3 | -0.4 | Upgrade
|
Asset Writedown | - | - | - | - | - | -40.6 | Upgrade
|
Legal Settlements | -213.7 | -203.5 | -15.8 | -20.6 | -405.4 | -33.4 | Upgrade
|
Other Unusual Items | -17.2 | 9 | 35.8 | 124.1 | -13.6 | -17.9 | Upgrade
|
Pretax Income | 1,751 | 1,598 | 1,767 | 1,702 | 916.7 | 1,167 | Upgrade
|
Income Tax Expense | 187.4 | 198.7 | 245.5 | 198.9 | 93.3 | 119.6 | Upgrade
|
Earnings From Continuing Operations | 1,564 | 1,399 | 1,522 | 1,503 | 823.4 | 1,047 | Upgrade
|
Minority Interest in Earnings | 3.8 | 3 | - | - | - | - | Upgrade
|
Net Income | 4,159 | 1,402 | 1,522 | 1,503 | 823.4 | 1,047 | Upgrade
|
Net Income to Common | 4,159 | 1,402 | 1,522 | 1,503 | 823.4 | 1,047 | Upgrade
|
Net Income Growth | 190.65% | -7.85% | 1.25% | 82.55% | -21.35% | 44.96% | Upgrade
|
Shares Outstanding (Basic) | 602 | 607 | 619 | 623 | 623 | 625 | Upgrade
|
Shares Outstanding (Diluted) | 603 | 609 | 624 | 631 | 632 | 637 | Upgrade
|
Shares Change (YoY) | -1.35% | -2.37% | -1.11% | -0.11% | -0.75% | -0.66% | Upgrade
|
EPS (Basic) | 6.91 | 2.31 | 2.46 | 2.41 | 1.32 | 1.68 | Upgrade
|
EPS (Diluted) | 6.89 | 2.30 | 2.44 | 2.38 | 1.30 | 1.64 | Upgrade
|
EPS Growth | 193.69% | -5.74% | 2.52% | 83.08% | -20.73% | 45.13% | Upgrade
|
Free Cash Flow | 515.5 | 642.8 | 973.6 | 1,406 | 647.3 | 928.5 | Upgrade
|
Free Cash Flow Per Share | 0.85 | 1.05 | 1.56 | 2.23 | 1.02 | 1.46 | Upgrade
|
Gross Margin | 76.60% | 77.02% | 79.96% | 76.13% | 75.36% | 74.37% | Upgrade
|
Operating Margin | 30.14% | 28.81% | 33.29% | 30.32% | 30.01% | 28.48% | Upgrade
|
Profit Margin | 65.86% | 23.35% | 28.28% | 28.73% | 18.77% | 24.08% | Upgrade
|
Free Cash Flow Margin | 8.16% | 10.70% | 18.09% | 26.88% | 14.76% | 21.35% | Upgrade
|
EBITDA | 2,052 | 1,875 | 1,932 | 1,721 | 1,423 | 1,328 | Upgrade
|
EBITDA Margin | 32.50% | 31.22% | 35.89% | 32.90% | 32.45% | 30.54% | Upgrade
|
D&A For EBITDA | 149.3 | 144.9 | 139.6 | 134.8 | 107.2 | 89.3 | Upgrade
|
EBIT | 1,903 | 1,730 | 1,792 | 1,587 | 1,316 | 1,239 | Upgrade
|
EBIT Margin | 30.14% | 28.81% | 33.29% | 30.32% | 30.01% | 28.48% | Upgrade
|
Effective Tax Rate | 10.70% | 12.43% | 13.89% | 11.69% | 10.18% | 10.25% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.